SUBSCRIBE
SUBSCRIBE

BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
84 Results
Year
Month
Day
Year
Month
Day
  • MedMira Announces Product Update
    Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its validated REVEALCOVID-19TM PLUS Total Antibody Test for the detection of total antibodies against both the Nucleocapsid and Spike regions of the SARS-CoV-2. REVEALCOVID-19TM PLUS Total Antibody Test
    December 30, 2020
     · 
    4 min read
  • Pharm Country
    Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors
    – Sulanda ® is Chi-Med’s first oncology drug brought to market without a partnership and the company’s second oncology drug approved in China – – The pivotal Phase III SANET-ep trial demonstrated surufatinib reduced risk of progression or death by 67%, extending PFS in all subgroups of non-pancreatic NET patients with an acceptable risk/benefit ratio – – ~400-strong oncology commercial team in place to bring Sulanda ® to patients in China – HONG KONG and FLORHAM PARK, N.J., Dec. 30,
    December 30, 2020
     · 
    9 min read
  • Tetra Bio-Pharma Files New Drug Submission for REDUVO(TM) in Canada
    The addressable market is estimated to be $80M CDN by 2022 Tetra meets another key milestone before the end of the year
    December 30, 2020
     · 
    4 min read
  • Pharm Country
    Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021
    Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at Biotech Showcase™ Digital 2021. The conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Spiro Rombotis, President & Chief Executive Office
    December 30, 2020
     · 
    3 min read